Efficacy and Safety of Camrelizumab Plus Apatinib in Patients With Refractory Chordoma: A Phase II Clinical Trial

Journal:

Journal of Clinical Oncology

Published:

2026-05-14

DOI:

10.1200/jco-25-02719

Affiliations:

5

Authors:

25

Go to article

Institutions	Authors	Share
Shanghai Changzheng Hospital, SMMU, China	22.000000 22.000000 22.000000	0.88
Second Military Medical University (SMMU), China	2.000000	0.08
PLA Navy No. 905 Hospital, China	1.000000	0.04

Interested in Oncology and Carcinogenesis?